CONDITION

Pancreatitis in Dogs

An inflammatory condition of the pancreas that causes abdominal pain, digestive disruption, and can range from mild to severe.

Why this matters now

Pancreatitis can affect dogs of any age, breed, or size, though middle-aged to older dogs appear to be more commonly diagnosed. Certain breeds, including Miniature Schnauzers (which may carry genetic predispositions affecting lipid metabolism), Yorkshire Terriers, Cocker Spaniels, and other small terrier breeds, may be overrepresented. Known risk factors include high-fat diets or dietary indiscretion (such as accessing fatty table scraps or rubbish), obesity, endocrine conditions such as hypothyroidism, hyperadrenocorticism, and diabetes mellitus, certain medications (including potassium bromide and some corticosteroid protocols), and hypertriglyceridaemia. However, in many cases, no specific trigger is identified. Pancreatitis can range from a single acute episode to a recurrent or chronic condition, and the initial presentation does not always predict the subsequent course.

The clinical course of canine pancreatitis is highly variable. Mild episodes may resolve with supportive care over a few days, whilst severe acute pancreatitis can progress rapidly to a life-threatening systemic illness involving multiple organ dysfunction. Between these extremes lies a spectrum of presentations that can be difficult to predict at the outset. Some dogs experience a single episode and never recur, whilst others develop a pattern of recurrent acute episodes or evolve into chronic pancreatitis with persistent low-grade inflammation and progressive loss of pancreatic tissue. Severe complications including pancreatic abscess formation, pseudocyst development, extrahepatic bile duct obstruction, and systemic inflammatory response syndrome (SIRS) can develop in a proportion of cases, fundamentally changing the clinical picture and management requirements.

Signals & patterns

Early signals

Vomiting

Vomiting is one of the most consistently observed signs of canine pancreatitis and may range from occasional episodes to persistent, intractable vomiting. The vomitus may contain food, bile, or foam, and the vomiting may occur shortly after eating or independently of meals. The frequency and intensity of vomiting generally correlate with the severity of the pancreatic inflammation, though this relationship is not absolute.

Abdominal pain

Dogs with pancreatitis often display signs of abdominal discomfort, which may manifest as a tense abdomen, reluctance to be touched around the belly, restlessness, or adoption of the characteristic 'prayer posture' (front legs extended forward with the chest lowered to the ground whilst the hindquarters remain elevated). Some dogs may show more subtle pain indicators such as a hunched back, stiffness, or simply a general look of discomfort. The pain arises from the inflammatory and enzymatic damage to the pancreas and surrounding tissues.

Loss of appetite

Reduced appetite or complete food refusal is common and may precede or accompany the onset of vomiting. Dogs that normally eat with enthusiasm may show disinterest in food, turn away from their bowl, or eat a few bites before stopping. The inappetence likely reflects a combination of nausea, abdominal discomfort, and the systemic effects of the inflammatory process.

Lethargy and depression

A marked reduction in energy, interest in surroundings, and responsiveness to stimuli is frequently observed. Affected dogs may be reluctant to engage in normal activities, appear withdrawn or subdued, and spend increased time lying down. The degree of lethargy often provides a rough indicator of disease severity, with more profoundly depressed dogs typically experiencing more significant illness.

Diarrhoea

Loose, watery, or unusually coloured stools may develop alongside or shortly after the onset of vomiting and abdominal pain. The diarrhoea may contain blood or mucus in some cases. Changes in stool character reflect the disruption to normal digestive processes and may also result from the direct effects of pancreatic inflammation on the adjacent intestinal tract.

Later signals

Dehydration and cardiovascular compromise

Sustained vomiting, diarrhoea, and reduced fluid intake can lead to clinically significant dehydration, manifesting as dry or tacky mucous membranes, prolonged skin tenting, sunken eyes, and increased heart rate. In severe cases, hypovolaemia (reduced circulating blood volume) can compromise cardiovascular function, leading to weak pulses, delayed capillary refill time, and potentially circulatory shock. These systemic effects represent a significant escalation in the severity of the condition.

Fever or hypothermia

Body temperature may become abnormal, with fever indicating active systemic inflammation or secondary infection, and hypothermia suggesting severe systemic compromise. The direction and magnitude of temperature change can provide prognostic information, with hypothermia in the context of severe pancreatitis being a concerning finding that suggests the body's homeostatic mechanisms are being overwhelmed.

Jaundice

Yellow discolouration of the gums, skin, and whites of the eyes may develop if pancreatic swelling or inflammation obstructs the common bile duct, which passes through or adjacent to the pancreas in dogs. Biliary obstruction impedes the normal flow of bile from the liver into the intestines, causing bilirubin to accumulate in the bloodstream. This complication may require specific attention beyond the management of the pancreatitis itself.

Respiratory distress

In severe cases, acute pancreatitis can trigger systemic complications including acute lung injury or acute respiratory distress syndrome (ARDS), characterised by increased respiratory rate and effort, laboured breathing, and reduced oxygen levels. This occurs as circulating inflammatory mediators damage the pulmonary vasculature and alveolar epithelium, allowing fluid to leak into the lung tissue. Respiratory compromise in the context of pancreatitis indicates severe systemic illness.

Click to read about the biological mechanisms

How this is usually investigated

Investigating suspected pancreatitis in dogs involves combining clinical findings with laboratory tests and imaging to build a diagnostic picture, as no single test is perfectly sensitive or specific. The investigation also aims to assess the severity of the episode, identify potential triggering factors, screen for complications, and evaluate for concurrent conditions that may be contributing to or resulting from the pancreatic inflammation.

Canine pancreatic lipase immunoreactivity (cPLI/Spec cPL)

Purpose: This blood test measures a lipase isoenzyme specific to the pancreas, providing the most sensitive and specific readily available marker for canine pancreatitis. Elevated cPLI levels support a diagnosis of pancreatitis, and the degree of elevation may provide some information about the severity of the inflammatory process, though the correlation is not absolute. A point-of-care SNAP test version provides rapid qualitative results that can help guide initial decision-making.
Considerations: No single test is 100 per cent sensitive or specific for pancreatitis. False negatives can occur, and mildly elevated results may not always indicate clinically significant disease. Results are most informative when interpreted alongside clinical signs, other blood work, and imaging findings. Serial measurements can help track the trajectory of the disease.

Abdominal ultrasonography

Purpose: Ultrasound allows direct visualisation of the pancreas and surrounding structures, potentially revealing pancreatic enlargement, altered echogenicity (changes in tissue brightness), peripancreatic fluid, fat inflammation (appearing as hyperechoic or 'bright' fat around the pancreas), and complications such as abscess or pseudocyst formation. Ultrasound can also assess the biliary system for obstruction and evaluate other abdominal organs for concurrent disease or complications.
Considerations: The sensitivity of abdominal ultrasound for detecting pancreatitis in dogs varies with operator experience and equipment quality, and a normal ultrasound examination does not exclude pancreatitis. Gas in the gastrointestinal tract can obscure the pancreatic region. Serial ultrasound examinations may be valuable for monitoring the progression of the disease and detecting developing complications.

Blood biochemistry and haematology

Purpose: Comprehensive blood work helps assess the systemic impact of pancreatitis, identify concurrent conditions, and screen for complications. Common findings may include elevated liver enzymes (reflecting hepatic involvement or biliary compromise), azotaemia (elevated kidney values suggesting dehydration or renal effects), electrolyte imbalances (particularly hypokalaemia and hypocalcaemia), hyperglycaemia or hypoglycaemia, hyperlipidaemia, and changes in white blood cell counts. These parameters provide important information about the severity and systemic reach of the disease.
Considerations: Many of the biochemical changes in pancreatitis are non-specific. Hypocalcaemia, when present, may carry prognostic significance. The distinction between pre-renal azotaemia (from dehydration) and intrinsic renal injury requires clinical correlation. Serial monitoring is valuable for tracking trends and detecting evolving complications.

Coagulation assessment

Purpose: In severe pancreatitis, the coagulation system may become activated, potentially leading to disseminated intravascular coagulation (DIC). Assessment of prothrombin time, activated partial thromboplastin time, fibrinogen, D-dimers, and platelet count can identify developing coagulopathy, which represents a serious complication. Early identification of coagulation abnormalities allows proactive management.
Considerations: Mild coagulation changes may be present without progressing to clinically significant DIC. The interpretation of coagulation parameters requires consideration of the clinical context, as other conditions can also alter these values. Not all veterinary practices have immediate access to comprehensive coagulation testing.

Lipid profile and triglyceride assessment

Purpose: Measuring serum triglyceride and cholesterol levels can identify hypertriglyceridaemia, which is both a risk factor for and potential consequence of pancreatitis, particularly in predisposed breeds such as Miniature Schnauzers. Identifying underlying lipid metabolism disorders is important for long-term management and prevention of recurrence. Severely elevated triglycerides can interfere with some laboratory tests, potentially affecting the interpretation of other blood work results.
Considerations: Lipaemia (visible milkiness of the serum due to elevated lipids) can interfere with numerous laboratory assays, potentially producing artifactual results. Ideally, lipid levels should be assessed when the acute episode has resolved and after a period of fasting. In breeds with known lipid metabolism abnormalities, baseline lipid assessment may be valuable for long-term management planning.

Options & trade-offs

Management of canine pancreatitis is primarily supportive, focusing on addressing the consequences of the inflammation — pain, dehydration, nausea, and nutritional disruption — whilst supporting the body's own resolution of the inflammatory process. There are currently no specific treatments that directly halt the enzymatic cascade once initiated, so management centres on creating the conditions most favourable for recovery. The intensity of management varies substantially based on the severity of the presentation.

Aggressive fluid therapy

Intravenous fluid therapy is a cornerstone of pancreatitis management, aimed at restoring hydration, maintaining pancreatic perfusion, correcting electrolyte imbalances, and supporting cardiovascular function. The rate and volume of fluid administration are tailored to the individual patient's degree of dehydration, ongoing losses, and cardiovascular status. Electrolyte supplementation, particularly potassium, is commonly required. In severe cases, colloid support may be used alongside crystalloid fluids to maintain oncotic pressure.

Trade-offs: Aggressive fluid therapy requires hospitalisation with intravenous catheter placement and ongoing monitoring. Over-zealous fluid administration can lead to fluid overload, particularly in patients with cardiac compromise. Careful monitoring of hydration status, urine output, body weight, and cardiovascular parameters is needed to guide appropriate fluid rates. The duration of fluid therapy depends on the severity and course of the illness.

Multimodal pain management

Effective analgesia is essential for patient comfort and may improve outcomes by reducing stress, supporting appetite recovery, and facilitating healing. Pain management protocols may include opioids (such as methadone, fentanyl, or buprenorphine), local anaesthetic techniques (such as lidocaine constant rate infusions), ketamine at sub-anaesthetic doses for its anti-hyperalgesic properties, and non-steroidal anti-inflammatory drugs (used cautiously given the potential for gastrointestinal and renal effects). A multimodal approach combining agents with different mechanisms of action often provides more effective pain control than any single agent.

Trade-offs: Some analgesic agents can cause sedation, nausea, or gastrointestinal slowing, which may complicate assessment and management. The use of NSAIDs requires careful consideration in dehydrated or cardiovascularly compromised patients due to renal and gastrointestinal risks. Pain assessment in dogs involves some subjectivity, and the adequacy of analgesia requires ongoing evaluation and adjustment.

Anti-nausea therapy and nutritional support

Anti-emetic medications such as maropitant (Cerenia) and ondansetron can help control vomiting and nausea, which is important for patient comfort and for enabling the resumption of nutritional intake. Current evidence supports early enteral nutrition in canine pancreatitis rather than prolonged fasting, as maintaining intestinal barrier function and providing nutritional support may improve outcomes. If oral intake is not tolerated, nasooesophageal or oesophagostomy feeding tubes can provide enteral nutrition, whilst parenteral nutrition may be considered in cases where enteral feeding is not possible.

Trade-offs: The traditional approach of withholding food ('pancreatic rest') has been largely superseded by current understanding favouring early nutrition, but the transition to feeding must be managed carefully based on the individual patient's tolerance. Feeding tube placement requires sedation or anaesthesia. Parenteral nutrition requires specialised formulations, dedicated intravenous access, and careful monitoring, and carries risks including catheter-related infections and metabolic complications.

Dietary management for prevention

For dogs recovering from pancreatitis or with a history of recurrent episodes, long-term dietary modification is typically a key preventive strategy. This generally involves feeding a consistent, moderate-to-low-fat diet, avoiding fatty table scraps, treats, and human foods, and preventing dietary indiscretion (scavenging, raiding rubbish bins). Commercial veterinary gastrointestinal or low-fat diets provide a convenient option for maintaining a controlled fat intake. In breeds with hypertriglyceridaemia, specific ultra-low-fat diets may be indicated.

Trade-offs: Strict dietary control requires commitment from all household members and vigilance about the dog's access to inappropriate food sources. Some dogs may find low-fat diets less palatable, though gradual transition and finding an accepted formulation can address this. Social situations (visits, holidays) where the dog may be offered inappropriate food by well-meaning individuals require proactive management. The optimal degree of fat restriction may vary between individuals.

Management of complications and concurrent conditions

Addressing specific complications such as biliary obstruction, pancreatic abscess or pseudocyst, DIC, or secondary infections may require targeted interventions beyond the standard supportive care. Managing concurrent conditions that may have triggered or be exacerbated by the pancreatitis — including diabetes mellitus, hyperadrenocorticism, hypothyroidism, or hypertriglyceridaemia — is important for both acute management and long-term prevention. Surgical intervention may rarely be required for complications such as bile duct obstruction or infected pancreatic necrosis.

Trade-offs: The management of complications can substantially increase the complexity, duration, and cost of treatment. Surgical intervention in the context of acute pancreatitis carries increased risk due to the inflamed, friable nature of the tissues and the potential systemic compromise of the patient. Balancing the management of multiple concurrent conditions requires careful coordination and may involve trade-offs between the optimal management of one condition and the requirements of another.

Common misconceptions

Misconception:

"Pancreatitis is always caused by the dog eating something fatty"

Reality:

Whilst dietary indiscretion and high-fat meals are recognised risk factors for pancreatitis in dogs, many cases occur without an identifiable dietary trigger. The condition can be associated with endocrine diseases, certain medications, genetic predispositions (particularly in Miniature Schnauzers), obesity, and other factors, or may be truly idiopathic. Focusing exclusively on dietary causes can lead to under-recognition of other contributing factors and missed opportunities for comprehensive prevention.

Misconception:

"Dogs with pancreatitis should not be fed until the vomiting stops completely"

Reality:

The traditional practice of prolonged fasting ('nil by mouth' or 'pancreatic rest') has been increasingly questioned by current research and clinical experience. Evidence now suggests that early enteral nutrition — reintroducing food as soon as nausea is controlled, even if vomiting has not completely resolved — may support intestinal barrier function, reduce bacterial translocation, and improve outcomes compared to prolonged fasting. The approach to feeding has shifted towards providing nutrition as early as it is tolerated, using small, frequent meals of easily digestible, moderate-to-low-fat food.

Misconception:

"Mild pancreatitis is not serious and does not need veterinary attention"

Reality:

Whilst many mild episodes of pancreatitis do resolve with appropriate supportive care, the condition can be unpredictable and has the potential to escalate rapidly. What appears to be a mild initial presentation can progress to severe disease, and the early stages of potentially severe pancreatitis may not be distinguishable from a mild episode on initial assessment alone. Additionally, recurrent mild episodes can lead to cumulative pancreatic damage and the eventual development of chronic complications including exocrine pancreatic insufficiency or diabetes mellitus.

Understanding pancreatitis as a condition with variable severity and a tendency towards recurrence in some dogs can help frame the ongoing relationship between diet, lifestyle, and pancreatic health. Dogs that have experienced pancreatitis may benefit from long-term dietary management and awareness of the factors that can precipitate future episodes. Monitoring for signs of chronic pancreatic damage, including the potential development of exocrine pancreatic insufficiency or diabetes mellitus, can support the early recognition of these secondary conditions. The field of veterinary pancreatology continues to evolve, with ongoing research into diagnostic markers, prognostic indicators, and management strategies.

Last reviewed: 24 April 2026 · Dr Alastair Greenway MRCVS